GenSight Biologics S.A. (EPA:SIGHT)
0.2650
+0.0365 (15.97%)
Apr 24, 2025, 5:35 PM CET
GenSight Biologics Employees
GenSight Biologics had 16 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€164,063
Profits / Employee
€875,063
Market Cap
34.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 5,620 |
emeis Société anonyme | 83,000 |
GenSight Biologics News
- 17 days ago - GenSight Biologics Announces the Filing of its 2024 Universal Registration Document - Business Wire
- 17 days ago - GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update - Business Wire
- 5 weeks ago - GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates - Business Wire
- 5 weeks ago - GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025 - Business Wire
- 7 weeks ago - GenSight Biologics S.A. reports FY results - Seeking Alpha
- 2 months ago - GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results - Business Wire
- 2 months ago - GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study - Business Wire
- 3 months ago - GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update - Business Wire